Invention Grant
- Patent Title: mTOR ligands and polynucleotides encoding mTOR ligands
-
Application No.: US14877295Application Date: 2015-10-07
-
Publication No.: US09301992B2Publication Date: 2016-04-05
- Inventor: Thomas David Reed , Amy H. Atzel
- Applicant: Intrexon Corporation
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox PLLC
- Main IPC: C12P7/36
- IPC: C12P7/36 ; C12P7/02 ; C12P19/14 ; C12C7/04 ; A61K38/16 ; C07K14/00 ; A61K48/00
Abstract:
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
Public/Granted literature
- US20160022766A1 mTOR Ligands and Polynucleotides Encoding mTOR Ligands Public/Granted day:2016-01-28
Information query
